Treatment of Diet-Related Disorders in Adult Diabetes

  • Ying-Xiao Li
  • Kai-Chun Cheng
  • Akihiro Asakawa
  • Akio Inui


Diabetes is a common metabolic disorder observed worldwide; therefore, the increase in the prevalence of diabetes must be ascribed to changes in lifestyle. Dietary intervention and lifestyle modification are highly effective means to prevent and treat obesity and/or diabetes. Gut motility disturbances exist in a number of patients with diabetes, resulting in malnutrition and weight loss. Therefore, the diet for diabetes patients should be consistent with general public health nutrition principles, i.e., a fat-reduced, fiber-rich, and low-energy-density carbohydrate-rich diet. This chapter provides an overview of these agents and their implications in order to provide more information on the treatment of diet-related disorders in diabetes.


Glycemic Control Celiac Disease Gastric Emptying Autonomic Neuropathy Nutritional Education 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



5-HydroxyTryptamine Receptor 4


Body Mass Index


Diabetes Control and Complications Trial


Gastroesophageal Reflux Disease




Phosphatidylinositol 3-Kinase


Tissue Transglutaminase Test


World Health Organization



The authors would like to acknowledge Dr. Inui and Dr. Asakawa for their dedicated work, who planned the studyand provided creative suggestions for improving the analysis. Also all authors contributed to the review and writing of the manuscript will be highly appreciated.


  1. Abell T, Lou J, Tabbaa M, Batista O, Malinowski S, Al Juburi A. Gastric electrical stimulation for gastroparesis improves nutritional parameters at short, intermediate, and long-term follow-up. JPEN J Parenter Enteral Nutr. 2003;27:277–81.PubMedCrossRefGoogle Scholar
  2. Abell TL, Bernstein RK, Cutts T, Farrugia G, Forster J, Hasler WL, McCallum RW, Olden KW, Parkman HP, Parrish CR, Pasricha PJ, Prather CM, Soffer EE, Twillman R, Vinik AI. Treatment of gastroparesis: a multidisciplinary clinical review. Neurogastroenterol Motil. 2006;18:263–83.PubMedCrossRefGoogle Scholar
  3. Ambizas EM, Ginzburg R. Lubiprostone: a chloride channel activator for treatment of chronic constipation. Ann Pharmacother. 2007;41:957–64.PubMedCrossRefGoogle Scholar
  4. Anitha M, Gondha C, Sutliff R, Parsadanian A, Mwangi S, Sitaraman SV, Srinivasan S. GDNF rescues hyperglycemia-induced diabetic enteric neuropathy through activation of the PI3K/Akt pathway. J Clin Invest. 2006;116:344–56.PubMedCrossRefGoogle Scholar
  5. Boyle PJ, Zrebiec J. Physiological and behavioral aspects of glycemic control and hypoglycemia in diabetes. South Med J. 2007;100:175–82.PubMedCrossRefGoogle Scholar
  6. Bromer MQ, Friedenberg F, Miller LS, Fisher RS, Swartz K, Parkman HP. Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis. Gastrointest Endosc. 2005;61:833–9.PubMedCrossRefGoogle Scholar
  7. Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP, Horowitz M. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15 000 adults. Arch Intern Med. 2001a;161:1989–96.PubMedCrossRefGoogle Scholar
  8. Bytzer P, Talley NJ, Jones MP, Horowitz M. Oral hypoglycaemic drugs and gastrointestinal symptoms in diabetes mellitus. Aliment Pharmacol Ther. 2001b;15:137–42.PubMedCrossRefGoogle Scholar
  9. Camilleri M. Clinical practice: Diabetic gastroparesis. N Engl J Med. 2007;356:820–9.Google Scholar
  10. Campbell L, Rossner S. Management of obesity in patients with Type 2 diabetes. Diabet Med. 2001;18:345–54.PubMedCrossRefGoogle Scholar
  11. Campfield LA, Smith FJ. Blood glucose dynamics and control of meal initiation: a pattern detection and recognition theory. Physiol. 2003;88:25–58.Google Scholar
  12. Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care. 1994;17:961–9.PubMedCrossRefGoogle Scholar
  13. Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med. 1995;122:481–6.PubMedGoogle Scholar
  14. Darwazeh AM. Mixed salivary glucose levels and candidal carriage in patients with diabetes mellitus. J Oral Path Med. 1991;20:280–3.CrossRefGoogle Scholar
  15. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;977–86.Google Scholar
  16. Garner DM. The effects of starvation on behavior: implications for dieting and eating disorders. Healthy Weight J. 1998;21:68–72.Google Scholar
  17. Gottesman I. Managing obesity and glycemic control in insulin-using patients: clinical relevance and practice recommendations. Diabetes Res Clin Pract. 2004;65:17–22.CrossRefGoogle Scholar
  18. Greenberg L. Case management implications of celiac disease. Prof Case Manag. 2008;13:211–7.PubMedGoogle Scholar
  19. Grey M, Berry D. Coping skills training and problem solving in diabetes. Curr Diab Rep. 2004;4:126–31.PubMedCrossRefGoogle Scholar
  20. Gumbiner B. Treating obesity in Type 2 diabetes: calories, composition and control. Diabetes Care. 1999;22:886–8.PubMedCrossRefGoogle Scholar
  21. Han TS, Feskens EJ, Lean ME, Seidell JC. Associations of body composition with type 2 diabetes mellitus. Diabet Med. 1998;15:129–35.PubMedCrossRefGoogle Scholar
  22. Heilbronn LK, Noakes M, Clifton PM. Effect of energy restriction, weight loss, and diet composition on plasma lipids and glucose in patients with type 2 diabetes. Diabetes Care. 1999;22:889–95.PubMedCrossRefGoogle Scholar
  23. Hill ID, Dirks MH, Liptak GS, Colletti RB, Fasano A, Guandalini S, Hoffenberg EJ, Horvath K, Murray JA, Pivor M, Seidman EG. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Pediatr Gastroenterol Nutr. 2005;40:1–19.CrossRefGoogle Scholar
  24. Hoeldtke RD, Bryner KD, McNeill DR, Hobbs GR, Riggs JE, Warehime SS, Christie I, Ganser G, Van Dyke K. Nitrosative stress, uric Acid, and peripheral nerve function in early type 1 diabetes. Diabetes. 2002;51:2817–25.PubMedCrossRefGoogle Scholar
  25. Horvath VJ, Vittal H, Lorincz A, Chen H, Almeida Porada G, Redelman D, Ordog T. Reduced stem cell factor links smooth myopathy and loss of interstitial cells of cajal in murine diabetic gastroparesis. Gastroenterology. 2006;130:759–70.PubMedCrossRefGoogle Scholar
  26. Horowitz M, Fraser RJ. Gastroparesis: diagnosis and management. Scand J Gastroenterol Suppl. 1995;213:7–16.PubMedGoogle Scholar
  27. Jones MP. Access options for withdrawn motility-modifying agents. Am J Gastroenterol. 2002;97:2184–8.PubMedCrossRefGoogle Scholar
  28. Kinekawa F, Kubo F, Matsuda K, Fujita Y, Tomita T, Uchida Y, Nishioka M. Relationship between esophageal dysfunction and neuropathy in diabetic patients. Am J Gastroenterol. 2001;96:2026–32.PubMedCrossRefGoogle Scholar
  29. Kuo P, Rayner CK, Jones KL, Horowitz M. Pathophysiology and management of diabetic gastropathy: a guide for endocrinologists. Drugs. 2007;67:1671–87.PubMedCrossRefGoogle Scholar
  30. Lata PF, Pigarelli DL. Chronic metoclopramide therapy for diabetic gastroparesis. Ann Pharmacother. 2003;37:122–6.PubMedCrossRefGoogle Scholar
  31. Leinninger GM, Edwards JL, Lipshaw MJ, Feldman EL. Mechanisms of disease: mitochondria as new therapeutic targets in diabetic neuropathy. Nat Clin Pract Neurol. 2006;2:620–8.PubMedCrossRefGoogle Scholar
  32. Leventhal H, Cameron L. Behavioural theories and the problem of compliance. Patient Educ Couns. 1987;10:117–38.CrossRefGoogle Scholar
  33. Lundgren H, Bengtsson C, Blohme G, Lapidus L, Sjo È stro Èm L. Adiposity and adipose tissue distribution in relation to incidence of diabetes in women: results from a prospective population study in Gothenburg, Sweden. Int J Obes. 1989;13:413–23.PubMedGoogle Scholar
  34. Lysy J, Israeli E, Strauss Liviatan N, Goldin E. Relationship between hypoglycaemia and gastric emptying abnormalities in insulin-treated diabetic patients. Neurogastroenterol Motil. 2006;18:433–40.PubMedCrossRefGoogle Scholar
  35. Maleki D, Locke GR 3rd, Camilleri M, Zinsmeister AR, Yawn BP, Leibson C, Melton LJ 3rd. Gastrointestinal tract symptoms among persons with diabetes mellitus in the community. Arch Intern Med. 2000;160:2808–16.PubMedCrossRefGoogle Scholar
  36. Mishra GD, Carrigan G, Brown WJ, Barnett AG, Dobson AJ. Short-term weight change and the incidence of diabetes in midlife: Results from the Australian Longitudinal Study on Women’s Health. Diabetes Care. 2007;30:1418–24.PubMedCrossRefGoogle Scholar
  37. National Institutes of Health, National Heart Lung and Blood Institute. Clinical guidelines for the identification, evaluation and treatment of overweight and obesity in adults: the evidence report. Bethesda: US Department of Health and Human Services, Public Health Service, NIH, NHLBI; 1998.Google Scholar
  38. Ohlson LO, Larsson B, Sva È rdsudd K, Welin L, Eriksson H, Whilhelmsen L. The influence of body fat distribution on the incidence of diabetes mellitus: 13 5 years of follow-up of the participants in the study of men born in 1913. Diabetes. 1985;34:1055–8.PubMedCrossRefGoogle Scholar
  39. Plodkowski RA, St Jeor ST. Medical nutrition therapy for the treatment of obesity. Endocrinol Metab Clin North Am. 2003;32:935–65.PubMedCrossRefGoogle Scholar
  40. Report of a WHO consultation on obesity. Obesity: preventing and managing the global epidemic. Geneva. 3–5 June; 1997.Google Scholar
  41. Rayner CK, Horowitz M. New management approaches for gastroparesis. Nat Clin Pract Gastroenterol Hepatol. 2005;2:454–62; quiz 493.PubMedCrossRefGoogle Scholar
  42. Rayner CK, Horowitz M. Gastrointestinal motility and glycemic control in diabetes: the chicken and the egg revisited. J Clin Invest. 2006;116:299–302.PubMedCrossRefGoogle Scholar
  43. Sellin JH, Chang EB. Therapy Insight: gastrointestinal complications of diabetesȓpathophysiology and management. Nat Clin Pract Gastroenterol Hepatol. 2008;5:162–71.PubMedCrossRefGoogle Scholar
  44. Shakil A, Church RJ, Rao SS. Gastrointestinal complications of diabetes. Am Fam Physician. 2008;77:1697–702.PubMedGoogle Scholar
  45. Talley NJ. Diabetic gastropathy and prokinetics. Am J Gastroenterol. 2003;98:264–71.PubMedCrossRefGoogle Scholar
  46. UK Prospective Diabetes Study (UKPDS). Group. Response of fasting plasma glucose to diet therapy in newly presenting type II diabetic patients (UKPDS 7). Metabolism. 1990;39:905–12.CrossRefGoogle Scholar
  47. Watkins PJ, Buxton Thomas MS, Howard ER. Long-term outcome after gastrectomy for intractable diabetic gastroparesis. Diabet Med. 2003;20:58–63.PubMedCrossRefGoogle Scholar
  48. Wing RR, Hill JO. Successful weight loss maintenance. Annu Rev Nutr. 2001;21:323–41.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Ying-Xiao Li
  • Kai-Chun Cheng
  • Akihiro Asakawa
  • Akio Inui
    • 1
  1. 1.Department of Psychosomatic Internal MedicineKagoshima University Graduate School of Medical and Dental Sciences 8-35-1 SakuragaokaKagoshimaJapan

Personalised recommendations